REMEGEN (09995) Sets 27 Mar 2026 Board Meeting to Review FY2025 Results and Dividend Proposal

Bulletin Express03-17

REMEGEN Co., Ltd. (09995) has scheduled a board meeting for 27 March 2026. Directors will review and approve the consolidated financial results for the year ended 31 December 2025 and consider a dividend distribution, if any.\n\nThe meeting notice was signed by Chairman and Executive Director Mr. Wang Weidong on 17 March 2026 in Yantai, PRC.\n\nBoard composition at the announcement date:\n• Executive Directors: Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian\n• Non-Executive Directors: Dr. Wang Liqiang, Dr. Su Xiaodi\n• Independent Non-Executive Directors: Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184348282?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184348282","market":"hk","top_or_hot":-1,"title":"REMEGEN (09995) Sets 27 Mar 2026 Board Meeting to Review FY2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>REMEGEN Co., Ltd. (09995) has scheduled a board meeting for 27 March 2026. Directors will review and approve the consolidated financial results for the year ended 31 December 2025 and consider a dividend distribution, if any.\\n\\nThe meeting notice was signed by Chairman and Executive Director Mr. Wang Weidong on 17 March 2026 in Yantai, PRC.\\n\\nBoard composition at the announcement date:\\n• Executive Directors: Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian\\n• Non-Executive Directors: Dr. Wang Liqiang, Dr. Su Xiaodi\\n• Independent Non-Executive Directors: Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>REMEGEN (09995) Sets 27 Mar 2026 Board Meeting to Review FY2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nREMEGEN (09995) Sets 27 Mar 2026 Board Meeting to Review FY2025 Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-17 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>REMEGEN Co., Ltd. (09995) has scheduled a board meeting for 27 March 2026. Directors will review and approve the consolidated financial results for the year ended 31 December 2025 and consider a dividend distribution, if any.\\n\\nThe meeting notice was signed by Chairman and Executive Director Mr. Wang Weidong on 17 March 2026 in Yantai, PRC.\\n\\nBoard composition at the announcement date:\\n• Executive Directors: Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian\\n• Non-Executive Directors: Dr. Wang Liqiang, Dr. Su Xiaodi\\n• Independent Non-Executive Directors: Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09995","symbol_name":"荣昌生物","start_time":0,"source_url":"","article_id":"1184348282","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184348282","pubTimestamp":1773736959,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"REMEGEN Co., Ltd. (09995) has scheduled a board meeting for 27 March 2026. Directors will review and approve the consolidated financial results for the year ended 31 December 2025 and consider a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09995":"荣昌生物"},"translate_title":"REMEGEN(09995)定于2026年3月27日召开董事会会议，审查2025财年业绩和股息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09995":1},"content_text":"REMEGEN Co., Ltd. (09995) has scheduled a board meeting for 27 March 2026. Directors will review and approve the consolidated financial results for the year ended 31 December 2025 and consider a dividend distribution, if any.\\n\\nThe meeting notice was signed by Chairman and Executive Director Mr. Wang Weidong on 17 March 2026 in Yantai, PRC.\\n\\nBoard composition at the announcement date:\\n• Executive Directors: Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian\\n• Non-Executive Directors: Dr. Wang Liqiang, Dr. Su Xiaodi\\n• Independent Non-Executive Directors: Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184348282","isCrawlerRequest":true}